SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 127 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | +33.3% | 516 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +50.0% | 516 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -60.0% | 516 | -51.0% | 0.00% | – |
| Q3 2016 | $5,000 | -70.6% | 1,052 | -59.1% | 0.00% | -100.0% |
| Q2 2016 | $17,000 | +6.2% | 2,570 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $16,000 | -38.5% | 2,570 | -40.1% | 0.00% | 0.0% |
| Q4 2015 | $26,000 | 0.0% | 4,290 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $26,000 | 0.0% | 4,290 | +11.7% | 0.00% | 0.0% |
| Q2 2015 | $26,000 | -55.2% | 3,840 | -59.5% | 0.00% | -50.0% |
| Q1 2015 | $58,000 | +9.4% | 9,490 | +25.2% | 0.00% | 0.0% |
| Q4 2014 | $53,000 | +39.5% | 7,580 | +60.6% | 0.00% | +100.0% |
| Q3 2014 | $38,000 | -77.9% | 4,720 | -79.0% | 0.00% | -80.0% |
| Q3 2011 | $172,000 | -33.6% | 22,500 | -19.6% | 0.01% | -16.7% |
| Q2 2011 | $259,000 | +4.0% | 28,000 | 0.0% | 0.01% | 0.0% |
| Q1 2011 | $249,000 | +29.7% | 28,000 | 0.0% | 0.01% | +20.0% |
| Q4 2010 | $192,000 | – | 28,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |